GlassScriptPhysician profile
John Sidney Elkins
NPI 1134190580
$546.45
in general payments reported to CMS, 2019-2025
13 companies · $71.27 in 2025
The $71.27 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.69 · 2020: $49.89 · 2021: $54.21 · 2022: $102 · 2023: $109 · 2024: $133 · 2025: $71.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $247.49 | 2022-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $85.58 | 2024 | Veozah |
| Novo Nordisk INC | $46.50 | 2020-2021 | |
| Abiomed | $38.88 | 2025 | |
| Abbvie INC. | $22.55 | 2021 | |
| Amgen INC. | $20.49 | 2020 | |
| Pfizer INC. | $17.11 | 2023 | |
| Pacira Therapeutics, INC. | $14.56 | 2021 | |
| Exact Sciences Corporation | $13.64 | 2024 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $13.39 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.96 | 2022 | |
| Olympus America INC. | $10.89 | 2019 | |
| Kinex Medical Company LLC | $3.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Elkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.